초록 ▼

This invention provides novel nanofiber enhanced surface area substrates and structures comprising such substrates for use in various medical devices, as well as methods and uses for such substrates and medical devices. In one particular embodiment, a method of administering a composition to a patie

This invention provides novel nanofiber enhanced surface area substrates and structures comprising such substrates for use in various medical devices, as well as methods and uses for such substrates and medical devices. In one particular embodiment, a method of administering a composition to a patient is disclosed which comprises providing a composition-eluting device, said composition-eluting device comprising at least a first surface and a plurality of nanostructures attached to the first surface, and introducing the composition-eluting device into the body of the patient.

대표청구항 ▼

What is claimed is: 1. A method of administering a composition to a patient, comprising: providing a composition-eluting device, said composition-eluting device comprising at least a first surface and a plurality of nanostructures attached to the first surface, wherein: the plurality of nanostructu

What is claimed is: 1. A method of administering a composition to a patient, comprising: providing a composition-eluting device, said composition-eluting device comprising at least a first surface and a plurality of nanostructures attached to the first surface, wherein: the plurality of nanostructures comprise nanofibers and/or nanotubes; and introducing the composition-eluting device into the body of the patient. 2. The method of claim 1, wherein: the plurality of nanostructures comprise a material independently selected from the group consisting of silicon, glass, quartz, metals and metal alloys, inorganic polymers and copolymers, thermoset plastics, organic polymers including proteins, TiO, ZnO, ZnS, ZnSe, ZnTe, CdS, CdSe, CdTe, HgS, HgSe, HgTe, MgS, MgSe, MgTe, CaS, CaSe, CaTe, SrS, SrSe, SrTe, BaS, BaSe, BaTe, GaN, GaP, GaAs, GaSb, InN, InP, InAs, InSb, PbS, PbSe, PbTe, AlS, AlP, AlSb, Ge, SiGe, SiO, SiO2, silicon carbide and silicon nitride. 3. The method of claim 1, wherein: the composition-eluting device comprises a microsphere. 4. The method of claim 1, wherein: the composition-eluting device comprises a porous microsphere. 5. The method of claim 1, further comprising: delivering the composition-eluting device to the intestine of a patient. 6. The method of claim 2, wherein: the plurality of nanostructures comprise an average length of from about 10 nm to about 500 microns. 7. The method of claim 6, wherein: the plurality of nanostructures comprise an average diameter of from about 5 nm to about 1 micron. 8. The method of claim 7, wherein: at least some of the plurality of nanostructures comprises hollow nanotubes and/or nanowires. 9. The method of claim 5, further comprising: contacting a first surface of the composition-eluting device with an intestinal biological tissue surface, whereby a friction force between the surfaces is created due to contact points between at least some of the plurality of nanostructures, which friction force is greater than a friction force between the two surfaces without the nanostructures. 10. The method of claim 9, wherein: the first surface of the composition-eluting device adheres to the intestinal biological tissue surface at least in part by entanglement with cells or extracellular matrix proximate the biological tissue surface. 11. The method of claim 9, wherein: the first surface of the composition-eluting device adheres to the intestinal biological tissue surface substantially by Van der Waals forces between the nanostructures and the biological tissue surface. 12. The method of claim 11, wherein: the Van der Waals forces comprise from about 0.1 N/cm2 to about 100 N/cm2. 13. The method of claim 12, wherein: the Van der Waals forces comprise from about 1.0 N/cm2 to about 25 N/cm2. 14. The method of 13, wherein: the Van der Waals forces comprise from about 2.0 N/cm2 to about 10 N/cm2. 15. The method of claim 11, wherein: there is a density of contact points per unit area of intestinal biological tissue surface, and the density of contact points comprises from about 1 contact point per micron2 of biological tissue surface to about 2000 contact points per micron2 of biological tissue surface. 16. The method of claim 11, wherein: there is a density of contact points per unit area of intestinal biological tissue surface, and the density of contact points comprises from about 50 contact point per micron2 of biological tissue surface to about 250 contact points per micron2 of biological tissue surface.